[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.19.31. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 919
Citations 0
Letters
January 2, 2013

Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Events

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Department of Medicine, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois (drankursethi@gmail.com).

JAMA. 2013;309(1):27. doi:10.1001/jama.2012.116644

To the Editor: The meta-analysis by Dr Rizos and colleagues1 synthesized the available evidence on omega-3 PUFA supplementation to prevent adverse cardiovascular outcomes. In addition to conventional random-effects meta-analyses, subgroup analyses and meta-regressions were performed. No association with type of prevention (ie, mixed or secondary) or omega-3 dose was found, and the authors did not demonstrate a net benefit from omega-3 PUFA supplementation after 2007. However, the type of omega-3 PUFA supplements and co-administered medications were not adequately explored.

First Page Preview View Large
First page PDF preview
First page PDF preview
×